Advanced company searchLink opens in new window

YZH PHARMA LIMITED

Company number 12350759

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Mar 2024 AA Total exemption full accounts made up to 31 March 2023
13 Mar 2024 MR01 Registration of charge 123507590001, created on 8 March 2024
01 Mar 2024 CS01 Confirmation statement made on 14 February 2024 with updates
20 Mar 2023 AA Total exemption full accounts made up to 31 March 2022
14 Feb 2023 CS01 Confirmation statement made on 14 February 2023 with updates
24 Oct 2022 CS01 Confirmation statement made on 24 October 2022 with updates
24 Oct 2022 PSC07 Cessation of Mohamed Sharief as a person with significant control on 11 October 2022
24 Oct 2022 PSC07 Cessation of Khadija Sami as a person with significant control on 11 October 2022
24 Oct 2022 PSC07 Cessation of Ruaa Hamdan as a person with significant control on 11 October 2022
24 Oct 2022 SH01 Statement of capital following an allotment of shares on 11 October 2022
  • GBP 110
24 Oct 2022 PSC02 Notification of Sharief Oakfield Shares Ltd as a person with significant control on 11 October 2022
24 Oct 2022 PSC07 Cessation of Raz Mohammad as a person with significant control on 11 October 2022
24 Oct 2022 AP01 Appointment of Mr Qamar Riaz as a director on 11 October 2022
27 Sep 2022 CS01 Confirmation statement made on 27 September 2022 with updates
27 Sep 2022 PSC01 Notification of Khadija Sami as a person with significant control on 21 September 2022
27 Sep 2022 PSC01 Notification of Ruaa Hamdan as a person with significant control on 21 September 2022
27 Sep 2022 PSC01 Notification of Mohamed Sharief as a person with significant control on 21 September 2022
21 Sep 2022 PSC01 Notification of Raz Mohammad as a person with significant control on 21 September 2022
21 Sep 2022 PSC07 Cessation of Oakfield Pharma Limited as a person with significant control on 21 September 2022
21 Sep 2022 PSC07 Cessation of Mohammed Umer as a person with significant control on 21 September 2022
18 Aug 2022 CS01 Confirmation statement made on 18 June 2022 with no updates
23 Jun 2022 TM01 Termination of appointment of Mohammed Umer as a director on 15 June 2022
17 Mar 2022 CH01 Director's details changed for Mr Suhail Sharief on 14 March 2022
20 Dec 2021 AA Total exemption full accounts made up to 31 March 2021
05 Aug 2021 AA Accounts for a dormant company made up to 31 March 2020